Thymosin Alpha-1

Source / Derivation:

Thymosin Alpha-1 (Tα1) is a synthetic peptide modeled after a naturally occurring thymic peptide. It plays a critical role in immune system regulation and modulation, supporting both innate and adaptive immune responses.

Thymosin Alpha-1

Mechanism of Action:

Tα1 binds to immune cells and promotes T-cell differentiation, activation, and maturation, while enhancing dendritic cell function and cytokine signaling. This modulation strengthens immune surveillance and helps balance pro- and anti-inflammatory pathways.

Clinical Relevance & Potential Outcomes:

Studies indicate Thymosin Alpha-1 may support enhanced immune resilience, improved response to infections, and immunomodulation in immune-compromised states. It is being investigated for therapeutic applications in viral infections, immune deficiencies, and as an adjunct to vaccines.

Intended Clinical Application:

Thymosin Alpha-1 may be relevant for patients requiring immune system support, enhanced defense against pathogens, or immunomodulatory therapy in clinical contexts of infection or immune dysfunction.

Formulation & Quality Specifications:

Delivered as a liquid prefilled pen
Purity: >98% (HPLC-validated)
Storage: 2–8 °C (refrigerated)
Documentation: Full CoA and MSDS available

Concentration:

Frequency:

Dosage (pen clicks):

Duration:

Notes:

10 mg/ml, total 3 ml, total 30 mg

Daily

1 month

A peptide with strong immunomodulatory effects, enhancing immune function, reducing inflammation, and potentially aiding in cancer and infection recovery.